Lori Whitemen, MOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 718 E 3rd St, Salem, OH 44460 Phone: 330-332-9986 |
Tara L. Bycroft, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1995 E State St, Salem, OH 44460 Phone: 330-332-7297 |
Ms. Melissa Sue Chadbourne, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7855 Pleasant Valley Ct, Salem, OH 44460 Phone: 330-207-2947 |
Ms. Michelle Burdett, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 718 E 3rd St, Suite A, Salem, OH 44460 Phone: 330-332-9986 Fax: 330-332-8899 |
Holly Dicicco, MOT, OTR/L Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 109 Blossom Ln, Salem, OH 44460 Phone: 330-337-3033 |
Gloria B. Cecil, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1995 E State St, Salem, OH 44460 Phone: 330-332-7297 |
News Archive
The IOF-Servier Young Investigator Research Grant has been awarded to Dr Mark Edwards, clinical research fellow at the MRC Lifecourse Epidemiology Unit at Southhampton General Hospital in the UK.
USAID's "IMPACTblog" introduces the newest installment of the agency's "Pounds of Prevention" series, which focuses on risk reduction activities in Bangladesh.
Adaptive Eyewear, a UK-based not-for-profit organisation which aims to provide vision correction solutions to people in the developing world, was recognized yesterday at the Clinton Global Initiative (CGI) Fifth Annual Meeting for its exemplary approach to address the significant shortage of eye care specialists and lack of vision infrastructure in Rwanda. Adaptive Eyewear's commitment to the people of Rwanda was announced at the session "Driving Disruptive Innovation at the Base of the Pyramid" on Wednesday 23rd September at 2:45pm.
ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that it has implemented a staffing plan to operate the company that anticipates licensing its lead development programs and resuming development of earlier stage product candidates.
› Verified 3 days ago